To determine if MiR181ab1 plays a functional role in other oncogenic KRAS–driven cancers, we evaluated its role in pancreatic ductal adenocarcinoma (PDAC), a highly lethal cancer in which KRAS mutations are present in over 90% of cases. Here, KRAS is linked to pancreatic ductal adenocarcinoma.